MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
financial instruments...
$21,575K
Total other income
(expense)
$20,016K
Loss on issuance of
financial instruments...
-$1,050K
Interest expense
(including related party...
$509K
Net income (loss)
before provision for...
$15,350K
Loss from operations
-$4,666K
Net income (loss)
$15,350K
Total cost and
expenses
$4,666K
General and
administrative expenses
$2,809K
Research and development
expenses
$1,857K
Back
Back
Income Statement
source: myfinsight.com
NKGen Biotech, Inc. (NKGN)
NKGen Biotech, Inc. (NKGN)